Introducing BalanCD HEK293 Viral Feed for Viral Vector Production

Webcast

Webcasts

Webinar Date/Time: Wed, Mar 8, 2023 11:00 AM EST

Join us for an exciting webcast introducing the first viral feed designed specifically for HEK293 cells. Learn more about how an uninterrupted supply of feed can help boost viral vector production.

Register Free: https://www.biopharminternational.com/bp_w/viral-feed

Event Overview:

Join FUJIFILM Irvine Scientific and host, BioPharm International, for an exciting webinar introducing the first viral feed designed specifically for HEK293 cells. BalancCD HEK293 Viral Feed is designed for use with small- to large-scale HEK293 suspension cultures for AAV production of multiple serotypes and a range of agnostic basal growth media and transfection methods.

Key Learning Objectives
An uninterrupted supply of feed can help boost viral vector production. In this webinar you will learn how to:

  • Convert from batch to fed batch for viral vector production
  • Maximize titers from a wide range of AAV serotypes
  • Optimize, simplify, and scale-up workflows for viral vector production
  • Generate more VG/capsid yields and multiple-fold increases in AAV titers

Who Should Attend

  • Process Development Scientists, Bioprocessing/Bioproduction
  • Research Directors, Bioprocessing/Bioproduction
  • Directors R &D, Cell Line Development / Cell and Gene Therapy
  • Scientists, Cell and Gene Therapy, Biologics Manufacturing
  • Supply chain/procurement managers, Cell and Gene Therapy


Speaker:

Omid Taghavian, PhD
Senior Scientist II, Gene Therapy R&D
FUJIFILM Irvine Scientific

Omid Taghavian, PhD, is a Senior Scientist II with FUJIFILM Irvine Scientific, leading the Media Development and Optimization group for Gene Therapy in R&D. His background is in Molecular Biotechnology. He has several years of research experience in infectious disease biomarkers and vaccine discovery and development.

Register Free: https://www.biopharminternational.com/bp_w/viral-feed

Recent Videos
Buy, Sell, Hold: Cell and Gene Therapy
Buy, Sell, Hold: Cell and Gene Therapy
Buy, Sell, Hold: Cell and Gene Therapy
Related Content
© 2024 MJH Life Sciences

All rights reserved.